| Franklin Australian Absolute Return Bond Fund (Managed Fund) (FRAR) |
Financials |
$696 |
Final Dividend Details 31 August 2024
|
28 Aug 2024 8:21AM |
$0.995 |
$1.045 |
risen by
5.03%
|
|
| Sovereign Metals Limited (SVM) ORDINARY FULLY PAID |
Materials |
$466 |
Hydraulic Mining Trial Commences
|
28 Aug 2024 8:21AM |
$0.605 |
$0.720 |
risen by
19.01%
|
|
SVM - Price-sensitive ASX Announcement
Full Release
Key Points
- Hydraulic mining trial commenced at Kasiya Pilot Site
- The trial is part of the ongoing Optimisation Study
- Conducted by Fraser Alexander, a leader in hydraulic mining
- Expected to take approximately three months, includes backfilling and rehabilitation testwork
- Kasiya’s soft, friable orebody is suitable for hydraulic mining
- Oversight by Sovereign-Rio Tinto Technical Committee
- Rio Tinto increases its shareholding to 19.9% with an additional investment of A$0.7 million
- Pilot Phase includes processing, backfilling material, and progressing towards rehabilitation
- No drilling, blasting, crushing, grinding, or milling needed before stockpiling material
- Land rehabilitation aims to restore land post-mining to match or surpass existing agricultural yields
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Origin Energy Limited (ORG) ORDINARY FULLY PAID |
Utilities |
$20,570 |
Changes to the Origin Board
|
28 Aug 2024 8:21AM |
$9.910 |
$11.940 |
risen by
20.48%
|
|
| Hiremii Limited (HMI) ORDINARY FULLY PAID |
Industrials |
$7 |
2024 Annual General Meeting - Key Dates
|
28 Aug 2024 8:20AM |
$0.045 |
$0.044 |
fallen by
2.22%
|
|
| Betmakers Technology Group Ltd (BET) ORDINARY FULLY PAID |
Consumer Discretionary |
$176 |
FY24 Results Webinar
|
28 Aug 2024 8:20AM |
$0.092 |
$0.160 |
risen by
73.91%
|
|
| Telstra Group Limited (TLS) ORDINARY FULLY PAID |
Communication Services |
$56,584 |
Notice of 2024 Annual General Meeting
|
28 Aug 2024 8:20AM |
$4.000 |
$4.970 |
risen by
24.25%
|
|
| EZZ Life Science Holdings Limited (EZZ) ORDINARY FULLY PAID |
Health Care |
$101 |
FY24 Full Year Results Summary
|
28 Aug 2024 8:19AM |
$1.950 |
$2.150 |
risen by
10.26%
|
|
EZZ - Price-sensitive ASX Announcement
Full Release
Key Points
- Record revenue of $66.4m, up 78.9% on the previous corresponding period (PcP)
- EBITDA of $10.4m, up 103.8% on the PcP
- Gross margin remained above 75% in FY24
- NPAT of $6.9m, up 91.8% on the PcP
- Operating cash flow of $6.2m, up 55% on the PcP
- Balance sheet strengthened with a cash position of $19.0m at 30 June 2024, up 37.5% on the PcP
- Fully franked interim dividend of $0.015 per share in FY24, up from $0.0098 per share in FY23
- Launched 21 new EZZ products in FY24, bringing the total active product portfolio to 53 SKUs
- Introduced 10 new distribution channels and expanded networks across key platforms including Douyin, Tmall Global, Kuaishou, Aubay, and O’Mall
- Growing brand awareness in the Chinese market
- Targeting US market expansion in FY25 by successfully obtaining FDA approvals for nine EZZ products in the food category
- Secured a strategic investor and a major sales agreement to expand distribution channels in existing and new markets within Southeast Asia
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Canterbury Resources Ltd (CBY) ORDINARY FULLY PAID |
Materials |
$5 |
Outstanding Drill Result at Briggs
|
28 Aug 2024 8:18AM |
$0.030 |
$0.024 |
fallen by
20%
|
|
CBY - Price-sensitive ASX Announcement
Full Release
Key Points
- Canterbury Resources Limited reported assay results for the first hole, 24BRD0026, in the 2024 drilling program at the Briggs copper-molybdenum project.
- Hole 24BRD0026 drilled to a depth of 283.9m intersected strong copper mineralisation, recording 276m at 0.45% Cu from surface, including multiple higher-grade intervals.
- Around 50% of the mineralisation in 24BRD0026 occurs outside the current boundary of the Briggs Central inferred resource.
- The drilling program is testing for near-surface, higher-grade copper mineralisation and aims to support a higher-grade starter-pit in a conceptual mining operation.
- Infill drilling is being undertaken to upgrade resource confidence to initiate a Scoping Study later in the year.
- Drilling in the area is continuing with holes 24BRD0027 and 24BRD0028 completed and hole 24BRD0029 nearing completion.
- Funding for the 2024 program is provided by Alma Metals Limited under an Earn-in Joint Venture Agreement, with Alma Metals expected to increase its project interest to 51% by meeting Stage-2 expenditure requirements this year.
- The Briggs deposit comprises an Inferred Resource (MRE) of 415Mt at 0.25% Cu and 31ppm Mo, with an exploration target of 480Mt to 880Mt at 0.20% to 0.30% Cu and 25ppm to 40ppm Mo.
- Preliminary metallurgical test-work has achieved high copper recoveries (92-95%) via standard crushing, grinding, and flotation.
- Copper mineralisation transitions from copper oxides and malachite at surface to chalcopyrite and secondary chalcocite at depth.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Telix Pharmaceuticals Limited (TLX) ORDINARY FULLY PAID |
Health Care |
$5,969 |
Telix Submits NDA for TLX101-CDx Brain Cancer Imaging Agent
|
28 Aug 2024 8:17AM |
$19.970 |
$17.640 |
fallen by
11.67%
|
|
TLX - Price-sensitive ASX Announcement
Full Release
Key Points
- Telix Pharmaceuticals Limited submits NDA to FDA for TLX101-CDx (Pixclara®) for brain cancer imaging.
- TLX101-CDx is a PET agent for glioma characterisation.
- Pixclara® has Orphan Drug and Fast Track designations by FDA.
- FET PET (Pixclara®) is included in international clinical practice guidelines.
- There is a critical unmet need in glioma diagnosis and management.
- Pixclara® aims to improve diagnosis and treatment decision-making for glioma patients.
- Pixclara® is also developed as a companion theranostic imaging agent for TLX101.
- Gliomas are the most common primary brain tumours with low survival rates.
- Conventional imaging methods like MRI have limitations for glioma characterisation.
- Telix's NDA submission for Pixclara® reflects commitment to neuro-oncology imaging improvements.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Adairs Limited (ADH) ORDINARY FULLY PAID |
Consumer Discretionary |
$385 |
Dividend/Distribution - ADH
|
28 Aug 2024 8:17AM |
$2.050 |
$2.180 |
risen by
6.34%
|
|
| Adairs Limited (ADH) ORDINARY FULLY PAID |
Consumer Discretionary |
$385 |
ADH FY2024 Corporate Governance Statement and Appendix 4G
|
28 Aug 2024 8:16AM |
$2.050 |
$2.180 |
risen by
6.34%
|
|
| Adairs Limited (ADH) ORDINARY FULLY PAID |
Consumer Discretionary |
$385 |
ADH FY2024 Results Presentation
|
28 Aug 2024 8:16AM |
$2.050 |
$2.180 |
risen by
6.34%
|
|
ADH - Price-sensitive ASX Announcement
Full Release
Key Points
- Total sales of $594.4 million, down 4.3% from FY23.
- Gross margin improved by 170 basis points to 60.3%.
- Underlying EBIT of $57.6 million, down 9.8%.
- Effective cost management with significant savings in warehouse costs.
- Net debt reduced by $10 million to $64.1 million.
- Total dividends of 12.0 cents per share for FY24.
- Future priorities include store expansion, inventory management, and leveraging customer data.
- Focus on new growth initiatives to drive sales and profitability in FY25.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Adairs Limited (ADH) ORDINARY FULLY PAID |
Consumer Discretionary |
$385 |
ADH FY2024 Results Announcement
|
28 Aug 2024 8:16AM |
$2.050 |
$2.180 |
risen by
6.34%
|
|
ADH - Price-sensitive ASX Announcement
Full Release
Key Points
- Comprehensive overview of financial performance for FY2024
- Key financial metrics: revenue growth, net profit, operating expenses
- Strategic initiatives: expansion plans, cost management strategies, sustainability efforts
- Detailed financial statements and management's discussion and analysis
- Future outlook and commitment to enhancing shareholder value
- Focused operational efficiency and market expansion
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Smartgroup Corporation Ltd (SIQ) ORDINARY FULLY PAID |
Industrials |
$1,103 |
Half Year Results 2024 Investor Presentation
|
28 Aug 2024 8:16AM |
$7.550 |
$8.130 |
risen by
7.68%
|
|
SIQ - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue of $148.5m, up 27% vs prior corresponding period (pcp)
- Operating EBITDA of $56.2m, up 20% vs pcp
- EBITDA Margin was 40% excluding costs associated with SA contract implementation
- NPATA of $34.1m, up 16% vs pcp
- Strong operating cash flow conversion at 108% of NPATA
- 2024 interim dividend of 17.5 cps fully franked
- 402,000 active customers at June, +17,000 vs pcp
- 64,600 novated leases under management, +6,300 vs pcp
- 30,600 fleet-managed vehicles, +4,400 vs pcp
- 27% growth in leasing settlements vs pcp
- EV orders 42% of total new car orders in H1 2024
- Successful divestment of two non-core businesses
- Ranked in the 98th percentile globally on Sustainalytics ESG Risk Rating
- Recognized as an Employer of Choice for Gender Equality by WGEA for 2023-2025
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Adairs Limited (ADH) ORDINARY FULLY PAID |
Consumer Discretionary |
$385 |
ADH FY2024 Annual Report and Appendix 4E
|
28 Aug 2024 8:16AM |
$2.050 |
$2.180 |
risen by
6.34%
|
|
ADH - Price-sensitive ASX Announcement
Full Release
Key Points
- Adairs Limited's FY24 Annual Report highlights group sales of $594.4 million, down 4.3% due to reduced customer traffic.
- The underlying group EBIT was $57.6 million, down 9.8%, with all brands improving gross margins.
- Strong cost management offset significant inflationary pressures.
- Online sales accounted for 29.4% of total group sales, driven by the new website and click & collect service.
- Adairs' loyalty program, Linen Lover, had one million members contributing 85% of Adairs sales.
- Mocka achieved a successful turnaround with underlying EBIT up $5.0 million to $6.5 million.
- The National Distribution Centre transition resulted in cost savings of $4.0 million in FY24.
- The company declared fully franked total dividends of 12.0 cents per share for FY24.
- Sustainability initiatives included removing single-use plastic carry bags and using sustainable packaging.
- Adairs aims to achieve net-zero Scope 1 and 2 emissions by 2030.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Xref Limited (XF1) ORDINARY FULLY PAID |
Information Technology |
$39 |
2024 Corporate Governance Statement & Appendix 4G
|
28 Aug 2024 8:16AM |
$0.185 |
$0.175 |
fallen by
5.41%
|
|
| Regal Asian Investments Limited (RG8) ORDINARY FULLY PAID |
Financials |
$299 |
Update - Notification of buy-back - RG8
|
28 Aug 2024 8:16AM |
$2.110 |
$2.000 |
fallen by
5.21%
|
|
| VGI Partners Global Investments Limited (VG1) ORDINARY FULLY PAID |
Financials |
$434 |
Update - Notification of buy-back - VG1
|
28 Aug 2024 8:16AM |
$1.920 |
$1.750 |
fallen by
8.85%
|
|
| Mach7 Technologies Limited (M7T) ORDINARY FULLY PAID |
Health Care |
$89 |
Investor Presentation FY2024 Results
|
28 Aug 2024 8:15AM |
$0.590 |
$0.380 |
fallen by
35.59%
|
|
M7T - Price-sensitive ASX Announcement
Full Release
Key Points
- Mach7 Technologies Limited achieved record results in FY2024.
- The company reported significant growth in revenue and profit.
- There was a substantial increase in Annual Recurring Revenue (ARR).
- Important partnerships and customer acquisitions were highlighted.
- The strategic focus remains on expanding the customer base and product offerings.
- Investments in technology and infrastructure were emphasized.
- The company's outlook for the next fiscal year is optimistic.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Smartgroup Corporation Ltd (SIQ) ORDINARY FULLY PAID |
Industrials |
$1,103 |
Half Year Results 2024 Media Release
|
28 Aug 2024 8:15AM |
$7.550 |
$8.130 |
risen by
7.68%
|
|
SIQ - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue of $148.5 million, up 27% from prior corresponding period
- Operating EBITDA of $56.2 million, up 20%
- NPATA increased by 16% to $34.1 million
- Interim dividend of 17.5 cents per share declared
- Significant demand for electric vehicles, accounting for 42% of new car lease orders
- South Australia Government contract won, adding 36,500 packaging customers
- Divestment of non-core businesses to focus on salary packaging, novated leasing, and fleet
- Enhanced customer experience through new digital assets and operational efficiency
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Flight Centre Travel Group Limited (FLT) ORDINARY FULLY PAID |
Consumer Discretionary |
$2,789 |
Corporate Governance Statement
|
28 Aug 2024 8:15AM |
$19.330 |
$12.800 |
fallen by
33.78%
|
|
| Flight Centre Travel Group Limited (FLT) ORDINARY FULLY PAID |
Consumer Discretionary |
$2,789 |
FY24 Appendix 4G
|
28 Aug 2024 8:15AM |
$19.330 |
$12.800 |
fallen by
33.78%
|
|
| Flight Centre Travel Group Limited (FLT) ORDINARY FULLY PAID |
Consumer Discretionary |
$2,789 |
Dividend/Distribution - FLT
|
28 Aug 2024 8:15AM |
$19.330 |
$12.800 |
fallen by
33.78%
|
|
| OFX Group Limited (OFX) ORDINARY FULLY PAID |
Financials |
$197 |
Update - Notification of buy-back - OFX
|
28 Aug 2024 8:15AM |
$2.080 |
$0.840 |
fallen by
59.62%
|
|
| Mach7 Technologies Limited (M7T) ORDINARY FULLY PAID |
Health Care |
$89 |
FY24 Results Highlights
|
28 Aug 2024 8:15AM |
$0.590 |
$0.380 |
fallen by
35.59%
|
|
M7T - Price-sensitive ASX Announcement
Full Release
Key Points
- Mach7 Technologies Limited (M7T) announced its FY24 results.
- The company reported continued strong growth in revenue and bookings.
- M7T achieved a record annual recurring revenue (ARR) of AUD 13 million.
- The company secured multiple new customer contracts and renewals.
- Significant expansion in the US and Asia-Pacific regions.
- Increased investment in product innovation and development.
- Positive cash flow from operations was achieved.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Goals & planningInvesting goal hubsSaving to build wealth
Saving for happy retirement 
Call 1300 880 160
Start a chat
Schedule a call
